Assessment of the Biochemical Indicators of Kidney Function in Patients with Gingivitis
Article Sidebar
-
Gingivitis, Biochemical Indicators, Kidney Function, Patients
Abstract
Gingivitis, a chronic inflammatory condition of the gums is caused by the accumulation of bacterial plaque. While once considered primarily a localised oral disease, recent research indicates that it can also be systemic - especially when associated with systemic inflammatory conditions, such as chronic kidney disease (CKD). Chronic kidney disease (CKD) is characterised by the loss of kidney function, systemic inflammation and immune dysregulation, which may impact on gum inflammation via common pathways. There seems to be a plausible link between oral health and the health of the kidneys, with both diseases sharing features such as increased inflammatory cytokines, oxidative stress and dysbiosis. The researchers studied 43 women with gingivitis to determine whether there was an association between the gum condition and early indicators of chronic kidney disease (CKD). They examined key biochemical and haematological markers in these patients. To study markers of systemic inflammation and renal disease, we determined the white blood cell (WBC) count, blood urea and serum creatinine concentration in the blood samples. The statistical analysis showed that the white blood cell count at 10.36 × 10³/μL is high, and it may mean that there is systemic inflammation, which may be linked to both gingival and renal disease. This was found to be significantly greater than the test value (P>0.05) despite being in the high-normal range. The average of 2.48 mg/dL of serum creatinine was higher than the recommended value of 1.3 mg/dL which suggests a reduction in glomerular filtration. Moreover, there was a significant impairment in renal function, with the average blood urea level of 40.45 mg/dL, which is well above the normal range of 7-20 mg/dL. These findings support the theory that renal failure and gingivitis go hand in hand, where inflammation in the mouth could worsen systemic immune response and CKD. Or, the destruction of periodontal tissue may be expedited by uremic toxins and immunosuppression in CKD. This study demonstrates that patients with renal disease or at risk of renal disease should receive a dental assessment and treatment.
Full text article
References
Aziz, M. (2024). "The Role of Microorganisms in Gingivitis Pathogenesis and Periodontal Disease". Journal of Odontology, 8(1), 705
Chaudhry, A., Kassim, N. K., Zainuddin, S. L. A., Taib, H., Ibrahim, H. A., Ahmad, B., ... & Adnan, A. S. (2022). Potential effects of Non-surgical Periodontal Therapy on Periodontal parameters, inflammatory markers, and kidney function indicators in chronic kidney disease patients with chronic Periodontitis. Biomedicines, 10(11), 2752.
Chen, L. P., Chiang, C. K., Chan, C. P., Hung, K. Y., & Huang, C. S. (2006). Does periodontitis reflect inflammation and malnutrition status in hemodialysis patients?. American journal of kidney diseases, 47(5), 815-822.
Deschamps‐Lenhardt, S., Martin‐Cabezas, R., Hannedouche, T., & Huck, O. (2019). Association between periodontitis and chronic kidney disease: Systematic review and meta‐analysis. Oral diseases, 25(2), 385-402.
Gasmi Benahmed, A., Kumar Mujawdiya, P., Noor, S., & Gasmi, A. (2022). Porphyromonas Gingivalis in the development of periodontitis: Impact on dysbiosis and inflammation. Archives of Razi Institute, 77(5), 1539–1551
D'souza, L. L., Lawande, S. A., Samuel, J., & Pinto, M. J. W. (2023). Effect of salivary urea, pH and ureolytic microflora on dental calculus formation and its correlation with periodontal status. Journal of Oral Biology and Craniofacial Research, 13(1), 8-12.
Fischer, R. G., Gomes Filho, I. S., CRUZ, S. S. D., Oliveira, V. B., Lira-Junior, R., Scannapieco, F. A., & Rego, R. O. (2021). What is the future of Periodontal Medicine?. Brazilian oral research, 35(Supp 2), e102..
Ioannidou, E., & Swede, H. (2011). Disparities in periodontitis prevalence among chronic kidney disease patients. Journal of Dental Research, 90(6), 730–734.
Jazmati, N. (2024). Intensive oral prophylaxis does not alter the tongue microbiome in young patients with chronic kidney disease: Longitudinal, randomized, controlled study. Frontiers in Immunology, 15, 1430655.
Keller, A., Rohde, J., Raymond, K., et al. (2015). Periodontal disease in patients with chronic kidney disease: a meta-analysis. Journal of Clinical Periodontology, 42(3), 258–266.
Eknoyan, G., Lameire, N., Eckardt, K., Kasiske, B., Wheeler, D., Levin, A., ... & Coresh, J. J. K. I. (2013). KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney int, 3(1), 5-14.
Kounis, N. G., Soufras, G. D., Tsigkas, G., & Hahalis, G. (2015). White blood cell counts, leukocyte ratios, and eosinophils as inflammatory markers in patients with coronary artery disease. Clinical and Applied Thrombosis/Hemostasis, 21(2), 139-143.
Abbud, M., Campos, H. H., Garcia, V. D., Pestana, J. O. M., Andreoni, K. A., Brayman, K. L., & Guidinger, M. K. (2007). Bibliography Current World Literature Vol 16 No 6 November 2007. Am J Transplant, 7(part 2), 1359-1375.
Laville, S. M., Couturier, A., Lambert, O., Metzger, M., Mansencal, N., Jacquelinet, C., ... & Massy, Z. A. (2023). Urea levels and cardiovascular disease in patients with chronic kidney disease. Nephrology Dialysis Transplantation, 38(1), 184-192.
Levey, A. S., & Coresh, J. (2012). Chronic kidney disease. The Lancet, 379(9811), 165–180.
Lucchese, A., Romano, A., Della Vella, F., Di Stasio, D., Serpico, R., & Petruzzi, M. (2021). Oral microbiota features in subjects with Down syndrome and periodontal diseases: A systematic review. International Journal of Molecular Sciences, 22(17), 9251.
Mahendra, J., Palathingal, P., Mahendra, L., Alzahrani, K. J., Banjer, H. J., Alsharif, K. F., ... & Patil, S. (2022). Impact of red complex bacteria and TNF-α levels on the diabetic and renal status of chronic kidney disease patients in the presence and absence of periodontitis. Biology, 11(3), 451.
Marchesan, J. T., Girnary, M. S., Moss, K., Monaghan, E. T., Egnatz, G. J., Jiao, Y., ... & Swanson, K. V. (2020). Role of inflammasomes in the pathogenesis of periodontal disease and therapeutics. Periodontology 2000, 82(1), 93-114.
Narimani, R., Esmaeili, M., Rasta, S. H., Khosroshahi, H. T., & Mobed, A. (2021). Trend in creatinine determining methods: Conventional methods to molecular‐based methods. Analytical Science Advances, 2(5-6): 308-325.
Nazir, M., Al-Ansari, A., Al-Khalifa, K., Alhareky, M., Gaffar, B., & Almas, K. (2020). Global prevalence of periodontal disease and lack of its surveillance. The Scientific World Journal. 1: 2146160.
Ni, Z., et al. (2017). Carbamylation in chronic kidney disease and its potential contribution to inflammation and cardiovascular disease. Kidney International, 91(3), 574–581.
Patil, A. M., Patil, M. D., & Birajdar, G. K. (2021). White blood cells image classification using deep learning with canonical correlation analysis. Irbm, 42(5), 378-389.
Preuss, H. G. (1993). Basics of renal anatomy and physiology. Clinics in laboratory medicine, 13(1), 1-11.
Rathee, M., & Jain, P. (2022). Gingivitis. StatPearls.
Janardhanan, N. (2024). Evaluation of Platelet-Neutrophil and Platelet-Monocyte Ratio in Healthy Subjects and Chronic Periodontitis Patients-A Clinical and Biochemical Analysis. RGUHS Journal of Dental Sciences, 16(2).
Saddique, Z., Faheem, M., Habib, A., UlHasan, I., Mujahid, A., & Afzal, A. (2023). Electrochemical creatinine (bio) sensors for point-of-care diagnosis of renal malfunction and chronic kidney disorders. Diagnostics, 13(10), 1737.
Schuetz, J. D. S., De Azambuja, C. B., Cunha, G. R., Cavagni, J., Rösing, C. K., Haas, A. N., ... & Fiorini, T. (2020). Association between severe periodontitis and chronic kidney disease severity in predialytic patients: A cross‐sectional study. Oral diseases, 26(2), 447-456.
Shimada, Y., Tabeta, K., Sugita, N., & Yoshie, H. (2013). Profiling biomarkers in gingival crevicular fluid using multiplex bead immunoassay. Archives of oral biology, 58(6), 724-730.
Imenez Silva, P. H., & Mohebbi, N. (2022). Kidney metabolism and acid–base control: back to the basics. Pflügers Archiv-European Journal of Physiology, 474(8), 919-934.
Sundström, J., Bodegard, J., Bollmann, A., Vervloet, M. G., Mark, P. B., Karasik, A., ... & Tangri, N. (2022). Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2• 4 million patients from 11 countries: The CaReMe CKD study. The Lancet Regional Health–Europe, 20.
Manu Rathee; Prachi Jain.Gingivitis(2025)National Library of Medicine
Trzcionka, A., Twardawa, H., Mocny-Pachońska, K., & Tanasiewicz, M. (2021, February). Periodontal treatment needs of hemodialized patients. In Healthcare (Vol. 9, No. 2, p. 139). MDPI.
Ullah, W., Nazir, A., Israr, H., Hussain, S., & Farooq, M. (2023). Assessment of serum urea and creatinine levels in diabetic patients. BioScientific Review, 5(3), 26-32.
Vanholder, R., Gryp, T., & Glorieux, G. (2018). Urea and chronic kidney disease: the comeback of the century?(in uraemia research). Nephrology Dialysis Transplantation, 33(1), 4-12.
Wu, H., Wang, S., & Wei, Z. (2024). Periodontitis and risk of mortality in patients with chronic kidney disease: A systematic review with meta‐analysis. Journal of Periodontal Research, 59(5), 868-876.
Zhou, Y., & Zheng, J. (2024). The role of the gut–kidney axis in chronic kidney disease. Frontiers in Physiology, 5, 1154980
Authors
This work is licensed under a Creative Commons Attribution 4.0 International License.